Press Release

HINGHAM, Mass. , Jan. 14, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent Office that it will grant a patent for Application No. 08738207, which covers the Company’s ViRob™ technology platform.

Regulatory Pre-Submission of the Self-Cleaning Shunt (SCS™) Remains the Primary Operational Objective HINGHAM, Mass. , Jan. 07, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) announced today anticipated operational and product milestones, including pivotal pre-clinical study and

HINGHAM, Mass. , Oct. 01, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that Harel Gadot , Chief Executive Officer, President, and

Larger-Scale Pre-Clinical Trial to Validate Positive Outcome of Initial Study; Company Aims to Initiate Regulatory Submissions in mid-2019 HINGHAM, Mass. , Oct. 01, 2018 (GLOBE NEWSWIRE) -- Following the successful outcome of the initial study, Microbot Medical Inc.

HINGHAM, Mass. , June 25, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that Intellectual Property India has granted patent No.

HINGHAM, Mass. , June 18, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that the European Patent Office (EPO) has notified the Company that

HINGHAM, Mass. , May 30, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it will host its periodical Townhall Meeting on Monday, June 4,

Significant Milestone Suggests Initial Safety Profile of the Self-Cleaning Shunt (SCS™) Product as the Company Moves Forward to Next Development Phase HINGHAM, Mass. , May 29, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ CM:MBOT), a medical device company specializing in the design and

HINGHAM, Mass. , May 25, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced the closing of the previously-announced acquisition of a novel